140 related articles for article (PubMed ID: 25686161)
1. IR-780 dye for near-infrared fluorescence imaging in prostate cancer.
Yi X; Yan F; Wang F; Qin W; Wu G; Yang X; Shao C; Chung LW; Yuan J
Med Sci Monit; 2015 Feb; 21():511-7. PubMed ID: 25686161
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of IR-780 dye-conjugated abiraterone for prostate cancer imaging and therapy.
Yi X; Zhang J; Yan F; Lu Z; Huang J; Pan C; Yuan J; Zheng W; Zhang K; Wei D; He W; Yuan J
Int J Oncol; 2016 Nov; 49(5):1911-1920. PubMed ID: 27633959
[TBL] [Abstract][Full Text] [Related]
3. Near‑infrared fluorescence imaging of prostate cancer using heptamethine carbocyanine dyes.
Yuan J; Yi X; Yan F; Wang F; Qin W; Wu G; Yang X; Shao C; Chung LW
Mol Med Rep; 2015 Feb; 11(2):821-8. PubMed ID: 25354708
[TBL] [Abstract][Full Text] [Related]
4. Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles.
Li S; Johnson J; Peck A; Xie Q
J Transl Med; 2017 Jan; 15(1):18. PubMed ID: 28114956
[TBL] [Abstract][Full Text] [Related]
5. Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.
Zhao N; Zhang C; Zhao Y; Bai B; An J; Zhang H; Wu JB; Shi C
Oncotarget; 2016 Aug; 7(35):57277-57289. PubMed ID: 27329598
[TBL] [Abstract][Full Text] [Related]
6. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging.
Zhang C; Liu T; Su Y; Luo S; Zhu Y; Tan X; Fan S; Zhang L; Zhou Y; Cheng T; Shi C
Biomaterials; 2010 Sep; 31(25):6612-7. PubMed ID: 20542559
[TBL] [Abstract][Full Text] [Related]
7. Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.
Huang CW; Li Z; Cai H; Shahinian T; Conti PS
Mol Imaging; 2011 Aug; 10(4):284-94. PubMed ID: 21486537
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
[TBL] [Abstract][Full Text] [Related]
9. The near-infrared fluorescent dye IR-780 was coupled with cabazitaxel for castration-resistant prostate cancer imaging and therapy.
Zheng Y; Hou G; Zhang G; Lan T; Yuan J; Zhang L; Yan F; Wang F; Meng P; Dun X; Li X; Chen G; Zhu Z; Wei D; He W; Yuan J
Invest New Drugs; 2020 Dec; 38(6):1641-1652. PubMed ID: 32361788
[TBL] [Abstract][Full Text] [Related]
10. Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancer.
Lütje S; Rijpkema M; Goldenberg DM; van Rij CM; Sharkey RM; McBride WJ; Franssen GM; Frielink C; Helfrich W; Oyen WJ; Boerman OC
Cancer Res; 2014 Nov; 74(21):6216-23. PubMed ID: 25252911
[TBL] [Abstract][Full Text] [Related]
11. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
Zhang C; Zhao Y; Zhao N; Tan D; Zhang H; Chen X; Zhang H; An J; Shi C; Li M
Contrast Media Mol Imaging; 2018; 2018():4979746. PubMed ID: 29706843
[TBL] [Abstract][Full Text] [Related]
12. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration.
Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y
Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728
[TBL] [Abstract][Full Text] [Related]
13. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
[TBL] [Abstract][Full Text] [Related]
14. Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells.
Wang Y; Liu T; Zhang E; Luo S; Tan X; Shi C
Biomaterials; 2014 Apr; 35(13):4116-24. PubMed ID: 24529902
[TBL] [Abstract][Full Text] [Related]
15. Intra-colonic administration of a polymer-bound NIRF probe for improved colorectal cancer detection during colonoscopy.
Kogan-Zviagin I; Shamay Y; Nissan A; Sella-Tavor O; Golan M; David A
J Control Release; 2014 Oct; 192():182-91. PubMed ID: 25008468
[TBL] [Abstract][Full Text] [Related]
16. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy.
Yue C; Liu P; Zheng M; Zhao P; Wang Y; Ma Y; Cai L
Biomaterials; 2013 Sep; 34(28):6853-61. PubMed ID: 23777910
[TBL] [Abstract][Full Text] [Related]
17. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
[TBL] [Abstract][Full Text] [Related]
18. IR-780 Dye as a Sonosensitizer for Sonodynamic Therapy of Breast Tumor.
Li Y; Zhou Q; Deng Z; Pan M; Liu X; Wu J; Yan F; Zheng H
Sci Rep; 2016 May; 6():25968. PubMed ID: 27174006
[TBL] [Abstract][Full Text] [Related]
19. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]